MedTrace Logo

Silkworm Pupa Powder Improves Dementia.

NCT06898476 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-05-04

No results posted yet for this study

Summary

The purpose of this clinical trial is to determine whether silkworm pupa powder is effective in treating Alzheimer's disease. It will also investigate whether silkworm pupa powder can improve the nutritional and frailty status of patients with Dementia. The main questions it aims to answer are:

* Will silkworm pupa powder improve the daily living conditions of patients with Alzheimer's disease?
* Will silkworm pupa powder improve the nutritional status and frailty of Alzheimer's disease patients?

Researchers will compare silkworm pupa powder with a placebo (a similar substance containing 0.5% silkworm pupa powder) to see if silkworm pupa powder can treat Alzheimer's disease.

Participants will:

* Take silkworm pupa powder or placebo daily for four months;
* Visit the clinic for check-ups and tests every four weeks;
* Record their symptoms and various physiological indicators.

Conditions

Interventions

DIETARY_SUPPLEMENT

Silkworm pupa powder

Silkworm pupa powder, 2 times a day, two packets (12\*2 g) each time, take with warm water, before meals, for three months

DIETARY_SUPPLEMENT

Placebo

Placebo, 2 sachets (12\*2 g) twice a day, with warm water, before meals, for three months

Sponsors & Collaborators

  • Hangzhou Institute of Medicine Chinese Academy of Sciences

    collaborator UNKNOWN

  • Zhejiang Provincial Tongde Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-10
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06898476 on ClinicalTrials.gov